Skip to main content
Log in

Dihydrotanshinone Attenuates LPS-Induced Acute Lung Injury in Mice by Upregulating LXRα

  • Original Article
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Dihydrotanshinone (DIH) is an extract of Salvia miltiorrhiza Bunge. It has been reported that DIH could regulate NF-κB signaling pathway. The aim of this study was to investigate whether DIH could protect mice from lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice. In this study, sixty mice were randomly divided into five groups, one group as blank control group, the second group as LPS control group, and the last three groups were pre-injected with different doses of DIH and then inhaled LPS for experimental comparison. After 12 h of LPS treatment, the wet-dry ratio, histopathlogical changes, and myeloperoxidase (MPO) activity of lungs were measured. In addition, ELISA kits were used to measure the levels of TNF-α and IL-1β inflammatory cytokines in bronchoalveolar lavage fluids (BALF), and western blot analysis was used to measure the activity of NF-κB signaling pathway. The results demonstrated that DIH could effectively reduce pulmonary edema, MPO activity, and improve the lung histopathlogical changes. Furthermore, DIH suppressed the levels of inflammatory cytokines in BALF, such as TNF-α and IL-1β. In addition, DIH could also downregulate the activity of NF-κB signaling pathway. We also found that DIH dose-dependently increased the expression of LXRα. In addition, DIH could inhibit LPS-induced IL-8 production and NF-κB activation in A549 cells. And the inhibitory effects were reversed by LXRα inhibitor geranylgeranyl pyrophosphate (GGPP). Therefore, we speculate that DIH regulates LPS-induced ALI in mice by increasing LXRα expression, which subsequently inhibiting NF-κB signaling pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Availability of Data and Materials

The data used to support the findings of this study are available from the corresponding author upon request.

References

  1. Parker, J.C. 2011. Acute lung injury and pulmonary vascular permeability: Use of transgenic models. Comprehensive Physiology 1: 835–882.

    Article  Google Scholar 

  2. Matuschak, G.M., and A.J. Lechner. 2010. Acute lung injury and the acute respiratory distress syndrome: Pathophysiology and treatment. Missouri Medicine 107: 252–258.

    PubMed  PubMed Central  Google Scholar 

  3. Tomashefski, J.F. 2000. Pulmonary pathology of acute respiratory distress syndrome. Clinics in Chest Medicine 21: 435–466.

    Article  Google Scholar 

  4. Chignard, M., and V. Balloy. 2000. Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccharide. American Journal of Physiology-Lung Cellular and Molecular Physiology 279: L1083–L1090.

    Article  CAS  Google Scholar 

  5. Blank, R., and L.M. Napolitano. 2011. Epidemiology of ARDS and ALI. Critical Care Clinics 27: 439–458.

    Article  Google Scholar 

  6. Chen, H., C. Bai, and X. Wang. 2010. The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine. Expert Review of Respiratory Medicine 4: 773–783.

    Article  CAS  Google Scholar 

  7. Lu, Y.C., W.C. Yeh, and P.S. Ohashi. 2008. LPS/TLR4 signal transduction pathway. Cytokine 42: 145–151.

    Article  CAS  Google Scholar 

  8. Kawai, T., and S. Akira. 2007. Signaling to NF-kappaB by Toll-like receptors. Trends in Molecular Medicine 13: 460–469.

    Article  CAS  Google Scholar 

  9. Endo-Umeda, K., and M. Makishima. 2019. Liver X receptors regulate cholesterol metabolism and immunity in hepatic nonparenchymal cells. International Journal of Molecular Sciences 20: 5045.

    Article  CAS  Google Scholar 

  10. Liebergall, S.R., J. Angdisen, S.H. Chan, Y.J. Chang, T.F. Osborne, A.F. Koeppel, S.D. Turner, and I.G. Schulman. 2020. Inflammation triggers liver X receptor-dependent lipogenesis. Molecular and Cellular Biology 40: e00364-e419.

    Article  CAS  Google Scholar 

  11. Miao, C.M., K. He, P.Z. Li, Z.J. Liu, X.W. Zhu, Z.B. Ou, X.Z. Ruan, J.P. Gong, and C.A. Liu. 2016. LXRalpha represses LPS-induced inflammatory responses by competing with IRF3 for GRIP1 in Kupffer cells. International Immunopharmacology 35: 272–279.

    Article  CAS  Google Scholar 

  12. Fu, Y.H., Y. Tian, Z.K. Wei, H. Liu, X.J. Song, W.B. Liu, W.L. Zhang, W.L. Wang, Y.G. Cao, and N.S. Zhang. 2014. Liver X receptor agonist prevents LPS-induced mastitis in mice. International Immunopharmacology 22: 379–383.

    Article  CAS  Google Scholar 

  13. Liu, B., Z.Q. He, J.J. Wang, Z.Y. Xin, J.X. Wang, F. Li, and Y.H. Fu. 2018. Taraxasterol inhibits LPS-induced inflammatory response in BV2 microglia cells by activating LXR alpha. Frontiers in Pharmacology 2018 (9): 278.

    Article  Google Scholar 

  14. Fu, Y.H., Z.Y. Xin, B. Liu, J.X. Wang, J.J. Wang, X. Zhang, Y.N. Wang, and F. Li. 2018. Platycodin D inhibits inflammatory response in LPS-stimulated primary rat microglia cells through activating LXR alpha-ABCA1 signaling pathway. Frontiers in Immunology 8: 1929.

    Article  Google Scholar 

  15. Su, K., G.X. Zhang, X. Zhang, and W. Jiang. 2019. Chikusetsusaponin V attenuates lipopolysaccharide-induced acute lung injury in mice by modulation of the NF-kappa B and LXR alpha. International Immunopharmacology 70: 174–179.

    Article  CAS  Google Scholar 

  16. Lee, D.S., S.H. Lee, J.G. Noh, and S.D. Hong. 1999. Antibacterial activities of cryptotanshinone and dihydrotanshinone I from a medicinal herb Salvia miltiorrhiza Bunge. Bioscience Biotechnology and Biochemistry 63: 2236–2239.

    Article  CAS  Google Scholar 

  17. Yuan, R.Y.K., L.T. Huang, L.J. Du, J.F. Feng, J. Li, Y.Y. Luo, Q.M. Xu, S.L. Yang, H.W. Gao, and Y.L. Feng. 2019. Dihydrotanshinone exhibits an anti-inflammatory effect in vitro and in vivo through blocking TLR4 dimerization. Pharmacological Research 142: 102–114.

    Article  CAS  Google Scholar 

  18. Guo, Y.L., X.X. Wu, Q. Wu, Y.F. Lu, J.S. Shi, and X.P. Chen. 2018. Dihydrotanshinone I, a natural product, ameliorates DSS-induced experimental ulcerative colitis in mice. Toxicology and Applied Pharmacology 344: 35–45.

    Article  CAS  Google Scholar 

  19. Zhao, W.W., C.X. Li, H.W. Gao, Q. Wu, J.S. Shi, and X.P. Chen. 2016. Dihydrotanshinone I attenuates atherosclerosis in ApoE-deficient mice: Role of NOX4/NF-kappa B mediated lectin-like oxidized LDL receptor-1 (LOX-1) of the Endothelium. Frontiers in Pharmacology 7: 418.

    PubMed  PubMed Central  Google Scholar 

  20. Zhou, X., V. Razmovski-Naumovski, D. Chang, C.G. Li, A. Kam, M. Low, A. Bensoussan, and K. Chan. 2016. Synergistic effects of Danshen (Salvia Miltiorrhiza Radix et Rhizoma) and Sanqi (Notoginseng Radix et Rhizoma) combination in inhibiting inflammation mediators in RAW264.7 cells. Biomed Research International.

  21. San, Z.H., Y.H. Fu, W. Li, E.S. Zhou, Y.M. Li, X.J. Song, T.C. Wang, Y. Tian, Z.K. Wei, M.J. Yao, et al. 2014. Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice. International Immunopharmacology 19: 342–350.

    Article  CAS  Google Scholar 

  22. Ruffini, E., A. Parola, E. Papalia, P.L. Filosso, M. Mancuso, A. Oliaro, G. Actis-Dato, and G. Maggi. 2001. Frequency and mortality of acute lung injury and acute respiratory distress syndrome after pulmonary resection for bronchogenic carcinoma. European Journal of Cardio-Thoracic Surgery 20: 30–37.

    Article  CAS  Google Scholar 

  23. Bruijn, M., L.B. van der Aa, R.R. van Rijn, A.P. Bos, and J.B.M. van Woensel. 2007. High incidence of acute lung injury in children with Down syndrome. Intensive Care Medicine 33: 2179–2182.

    Article  CAS  Google Scholar 

  24. Abraham, E., A. Carmody, R. Shenkar, and J. Arcaroli. 2000. Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. American Journal of Physiology-Lung Cellular and Molecular Physiology 279: L1137–L1145.

    Article  CAS  Google Scholar 

  25. Yamasawa, H., Y. Ishii, and S. Kitamura. 1999. Cytokine-induced neutrophil chemoattractant in a rat model of lipopolysaccharide-induced acute lung injury. Inflammation 23: 263–274.

    CAS  PubMed  Google Scholar 

  26. Wright, J.G., and J.W. Christman. 2003. The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: Implications for therapy. American Journal of Respiratory Medicine 2: 211–219.

    Article  CAS  Google Scholar 

  27. Maruyama, K., Y. Takada, N. Ray, Y. Kishimoto, J.M. Penninger, H. Yasuda, and K. Matsuo. 2006. Receptor activator of NF-kappa B ligand and osteoprotegerin regulate proinflammatory cytokine production in mice. Journal of Immunology 177: 3799–3805.

    Article  CAS  Google Scholar 

  28. Rahman, A., and F. Fazal. 2011. Blocking NF-kappaB: An inflammatory issue. Proceedings of the American Thoracic Society 8: 497–503.

    Article  CAS  Google Scholar 

  29. Zhu, R.T., Z.B. Ou, X.Z. Ruan, and J.P. Gong. 2012. Role of liver X receptors in cholesterol efflux and inflammatory signaling. Molecular Medicine Reports 5: 895–900.

    Article  CAS  Google Scholar 

  30. Jin, S.H., J.H. Yang, B.Y. Shin, K. Seo, S.M. Shin, I.J. Cho, and S.H. Ki. 2013. Resveratrol inhibits LXR alpha-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction. Toxicology and Applied Pharmacology 271: 95–105.

    Article  CAS  Google Scholar 

  31. Fu, Y.H., X.Y. Hu, Y.G. Cao, Z.C. Zhang, and N.S. Zhang. 2015. Saikosaponin a inhibits lipopolysaccharide-oxidative stress and inflammation in Human umbilical vein endothelial cells via preventing TLR4 translocation into lipid rafts. Free Radical Biology and Medicine 89: 777–785.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Xueshibojie Liu designed the experiment; Xueshibojie Liu, Jinghui Yang, Jing Yue, Guangxin Zhang, and Kai Su did the experiment; Chengbi Xu analyzed the data; Xueshibojie Liu wrote the paper; Jing Yue, Kai Su, and Guangxin Zhang revised the paper.

Corresponding author

Correspondence to Xueshibojie Liu.

Ethics declarations

Ethics Approval and Consent to Participate

All the experimental protocols in this study were approved by the Institutional Animal Care and Use Committee of Jilin University. All authors consent to participate this research.

Consent for Publication

All authors consent to publish this article.

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yue, J., Su, K., Zhang, G. et al. Dihydrotanshinone Attenuates LPS-Induced Acute Lung Injury in Mice by Upregulating LXRα. Inflammation 45, 212–221 (2022). https://doi.org/10.1007/s10753-021-01539-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-021-01539-3

KEY WORDS

Navigation